<DOC>
	<DOCNO>NCT00459173</DOCNO>
	<brief_summary>The primary study objective evaluate efficacy 2 dose level rimonabant ( 5 mg 20 mg ) maintenance abstinence smoking . Secondary objective evaluate effect rimonabant crave weight , clinical biological safety 2 dos rimonabant rimonabant 12-month treatment period evaluate pharmacokinetics drug .</brief_summary>
	<brief_title>Efficacy Safety Rimonabant Aid Maintenance Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Rimonabant</mesh_term>
	<criteria>Smokers smoke least 10 cigarettes/day mean within 2 month precede screen visit Motivated quit score great equal 6 tenpoint Motivation Scale non tobacco cigarettes consumption chronic use marijuana pregnancy , breastfeed clinically significant disease might interfere efficacy safety evaluation study drug Concomitant use drug aid smoke cessation might induce weight change</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>abstinence</keyword>
	<keyword>maintenance</keyword>
</DOC>